The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia
Phase of Trial: Phase IV
Latest Information Update: 19 May 2015
At a glance
- Drugs Desmopressin (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- Acronyms Nocturia-SMBP
- 19 May 2015 Results presented at the 110th Annual Meeting of the American Urological Association.
- 06 Dec 2013 Planned end date changed from 1 Apr 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov record.
- 23 Apr 2012 New trial record